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Recently,bioethicistEzekielEmanuel,MD, PhD, MSc, of the University ofPennsylvania, stirred up some con-
troversybysuggesting in theNewYorkTimes
that yearly checkups are a waste of time
(http://nyti.ms/193cv6J). As part of his ar-
gument, he cited a Cochrane Collaboration
systematic review that concluded that gen-
eral health checkups do not reducemortal-
ity.Given that thesevisits cancostbillionsof
dollars a year, he argued that they were an
unnecessary extravagance (http://bit.ly
/1DRmyXw).
Many have countered in recent weeks,
though, that mortality is a poor choice for
outcomes in such an evaluation. After all,
many good things can come out of check-
ups beyond a decrease inmortality. Helping
patients avoid death is not the only thing
physic ians try to do when they see
patients.
Moreover, the way our health care sys-
tem is set up, yearly examinations are often
where screening occurs. There are rela-
tively few other opportunities to check
healthypeople fordiseasesordisorders that
could affect them.Many of these screening
opportunities are recommended by the
UnitedStatesPreventiveServicesTaskForce
(USPSFT).
Does Screening Save Lives?
Butdoes screeninghealthy individuals save
lives? A new study by John Ioannidis, MD,
DSc, of Stanford University, and colleagues
suggests the answer is no (http://bit.ly
/15utVHU).
The researchers conducted literature
searches to identify recommendations for
screening tests that would be given to
healthy nonpregnant adults. Of 50 dis-
eases for which the USPSTF has published
statements, they selected 19 diseases that
had mortality as a common outcome, 12 of
them involving cancer, 5 cardiovascular dis-
ease, 2 diabetes, and 1 for chronic obstruc-
tive pulmonary disease.
Those 19 diseases had a lot of research
behind them. Forty-eight randomized trials
were available, as well as 9 meta-analyses.
Inonly4of themeta-analyses, however, did
screening tests significantly affect disease-
specific mortality. These included ultra-
sound screening for abdominal aortic aneu-
rysm in men; mammography screening for
breast cancer in women; and fecal occult
bloodtestingand flexible sigmoidoscopy for
colorectal cancer in men and women. Even
some of these, however, did not affect all-
cause mortality (http://bit.ly/1DycjrR).
So,more than half of themeta-analyses
found no reduction even in disease-specific
mortalityasassociatedwithscreening.More-
over, theresultsfromthemanyindividualran-
domizedtrialsareequallyunsupportive.Only
30%ofscreeningstudiesshowedasignificant
effect ondisease-specificmortality, andonly
11%affected all-causemortality.
This studywas accompanied by 3 com-
mentaries, each of which presented some
important considerations and thoughts
aboutwhat these resultsmean.First, it’s im-
portant to realize that, as with checkups,
mortality is not the only outcome that
matters (http://bit.ly/1z25BEY).Tryingto im-
prove quality of life or reducemorbidity are
also important outcomes. However, these
outcomes are not usually stressed when it
comes to screening.Whenwe think of why
women undergo mammography or why
men have their prostate-specific antigen
level checked, it’s usually because they are
afraid of diseases that can kill them.
There’s also a lot of research about
screening for the 19 diseases that the Ioan-
nidisandcolleaguesdidnotconsider, includ-
ing data from epidemiological studies. But
the evidence their review focused on is the
most relevant, given that epidemiological
studies can be confounded in many ways.
What’s the Harm?
We have to remember that screening
matters only if detecting a disease early
makes a real difference in terms of out-
comes, and if screening leads to a signifi-
cant decrease in the detection of advanced
disease (http://bit.ly/1M7oMq1). In prac-
tice, screening often doesn’t lead to earlier
diagnosis (http://1.usa.gov/193e7gK). Addi-
tionally, the later development of better
treatments for later-stage disease can
mitigate the advantages seen from screen-
ing inearlier studies (http://bit.ly/1CbQCvN).
What screen-
ing of ten does ,
though, is cause
some level of harm.
Overdiagnosis and
overtreatment can
have detrimental
consequences.Even
the psychological
worry from a false-
positive result can have real-world implica-
tions.
Thesearescreeningtestsrecommended
by theUSPSTF, and the evidence for them is
scant.Manyotherscreeningtestsdonebyphy-
siciansdon’tevenhavethis levelofsupportive
evidence. Further, becauseof theAffordable
CareAct, insurancemustpayforall screening
tests recommended by the USPSTF with a
gradeofAorB,regardlessofwhethertheyare
cost-effective (http://nyti.ms/1zqkzUi).
In spite of this, many people, including
many physicians, still maintain that screen-
ing tests and the annual checkups in which
theyoccurhavemerit.There’sagoodchance
that they’re right. But at this time, the argu-
ments being offered are not supported by
robust evidence.
If other outcomes matter, then they
should be put front and center. If what we
aredoinghasmerit outsideofmortalitypre-
vention, an explicit case needs to be made
for those gains. Otherwise, we are not only
encouraging,butmandating, thatourhealth
caredollarsbespent inaway that seemsun-
justifiable to many.
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